STOCK TITAN

AbCellera to Present at Upcoming Investor Conferences in September

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

AbCellera (ABCL) has announced its participation in two upcoming investor conferences in September 2024. The company will present at the Wells Fargo Healthcare Conference on September 5 at 12:00 p.m. Pacific Time, and the Cantor Global Healthcare Conference on September 17 at 8:30 a.m. Pacific Time.

Investors and interested parties can access live audio webcasts of both presentations through links that will be available on AbCellera's Investor Relations website. Replays of the webcasts will also be accessible through the same links after the presentations conclude.

These conferences provide AbCellera with opportunities to showcase its latest developments and engage with the investment community, potentially impacting its stock performance and market perception.

AbCellera (ABCL) ha annunciato la sua partecipazione a due prossime conferenze per investitori a settembre 2024. L'azienda presenterà alla Wells Fargo Healthcare Conference il 5 settembre alle 12:00 ora del Pacifico, e alla Cantor Global Healthcare Conference il 17 settembre alle 8:30 ora del Pacifico.

Gli investitori e le parti interessate possono accedere alle trasmissioni audio in diretta di entrambe le presentazioni tramite i link che saranno disponibili sul sito web delle Relazioni con gli Investitori di AbCellera. Anche le registrazioni delle trasmissioni saranno accessibili tramite gli stessi link dopo la conclusione delle presentazioni.

Queste conferenze offrono ad AbCellera opportunità per mettere in evidenza i suoi ultimi sviluppi e interagire con la comunità degli investitori, influenzando potenzialmente le prestazioni delle sue azioni e la percezione del mercato.

AbCellera (ABCL) ha anunciado su participación en dos próximas conferencias para inversores en septiembre de 2024. La compañía presentará en la Wells Fargo Healthcare Conference el 5 de septiembre a las 12:00 p.m. hora del Pacífico, y en la Cantor Global Healthcare Conference el 17 de septiembre a las 8:30 a.m. hora del Pacífico.

Los inversores y las partes interesadas pueden acceder a las transmisiones en vivo de ambas presentaciones a través de enlaces que estarán disponibles en el sitio web de Relaciones con Inversores de AbCellera. También se podrán acceder a las repeticiones de las transmisiones a través de los mismos enlaces después de que concluyan las presentaciones.

Estas conferencias brindan a AbCellera oportunidades para mostrar sus últimos desarrollos e interactuar con la comunidad inversora, lo que podría impactar en el rendimiento de sus acciones y en la percepción del mercado.

AbCellera (ABCL)는 2024년 9월에 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 9월 5일 태평양 표준시로 오후 12시에 웰스파고 헬스케어 회의에서 발표하고, 9월 17일 태평양 표준시로 오전 8시 30분에 칸토 글로벌 헬스케어 회의에서 발표할 예정입니다.

투자자와 관심 있는 세력은 AbCellera의 투자자 관계 웹사이트에서 제공되는 링크를 통해 두 발표의 실시간 오디오 웹캐스트에 접근할 수 있습니다. 발표가 끝난 후 동일한 링크를 통해 웹캐스트의 재방송도 접근할 수 있습니다.

이 회의는 AbCellera에게 최신 개발 사항을 선보이고 투자 커뮤니티와 소통할 수 있는 기회를 제공하며, 그에 따라 주식 성과 및 시장 인식에 영향을 미칠 수 있습니다.

AbCellera (ABCL) a annoncé sa participation à deux conférences pour investisseurs prévues en septembre 2024. La société présentera lors de la Wells Fargo Healthcare Conference le 5 septembre à 12 h 00, heure du Pacifique, et lors de la Cantor Global Healthcare Conference le 17 septembre à 8 h 30, heure du Pacifique.

Les investisseurs et les parties intéressées pourront accéder à des webcasts audio en direct des deux présentations via des liens qui seront disponibles sur le site des relations investisseurs d'AbCellera. Les replays des webcasts seront également accessibles via les mêmes liens après la fin des présentations.

Ces conférences offrent à AbCellera l'occasion de mettre en avant ses derniers développements et d'interagir avec la communauté des investisseurs, ce qui pourrait potentiellement avoir un impact sur la performance de ses actions et sur la perception du marché.

AbCellera (ABCL) hat seine Teilnahme an zwei kommenden Investorenkonferenzen im September 2024 angekündigt. Das Unternehmen wird am 5. September um 12:00 Uhr pacific time auf der Wells Fargo Healthcare Conference präsentieren und am 17. September um 8:30 Uhr pacific time auf der Cantor Global Healthcare Conference.

Investoren und interessierte Parteien können auf der Website für Investor Relations von AbCellera Live-Audio-Webcasts beider Präsentationen über Links zugreifen, die dort verfügbar sein werden. Nach Abschluss der Präsentationen werden auch Aufzeichnungen der Webcasts über dieselben Links zugänglich sein.

Diese Konferenzen bieten AbCellera Möglichkeiten, seine neuesten Entwicklungen zu präsentieren und mit der Investment-Community in Kontakt zu treten, was potenziell die Aktienperformance und die Marktperzeption beeinflussen könnte.

Positive
  • None.
Negative
  • None.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following investor conferences:

  • Wells Fargo Healthcare Conference on Thursday, September 5, 2024, at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time)
  • Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)

Live audio webcasts of each presentation may be accessed through links that will be posted on AbCellera's Investor Relations website. Replays of each webcast will be available through the same links following the presentations.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.

Inquiries

Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When is AbCellera (ABCL) presenting at the Wells Fargo Healthcare Conference in 2024?

AbCellera (ABCL) is presenting at the Wells Fargo Healthcare Conference on Thursday, September 5, 2024, at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time).

What time is AbCellera (ABCL) scheduled to present at the Cantor Global Healthcare Conference in September 2024?

AbCellera (ABCL) is scheduled to present at the Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time).

How can investors access AbCellera's (ABCL) presentations at the September 2024 investor conferences?

Investors can access live audio webcasts of AbCellera's (ABCL) presentations through links that will be posted on the company's Investor Relations website. Replays will also be available through the same links following the presentations.

Which investor conferences is AbCellera (ABCL) participating in during September 2024?

AbCellera (ABCL) is participating in two investor conferences in September 2024: the Wells Fargo Healthcare Conference and the Cantor Global Healthcare Conference.

AbCellera Biologics Inc. Common Shares

NASDAQ:ABCL

ABCL Rankings

ABCL Latest News

ABCL Stock Data

817.70M
294.67M
28.05%
38.35%
5.89%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
VANCOUVER